Zobrazeno 1 - 10
of 25
pro vyhledávání: '"R, Molero Gómez"'
Publikováno v:
Farmacia Hospitalaria, Volume: 38, Issue: 2, Pages: 123-129, Published: APR 2014
Farmacia Hospitalaria, Vol 38, Iss 2, Pp 123-129 (2014)
Farmacia Hospitalaria, Vol 38, Iss 2, Pp 123-129 (2014)
Objetivo: Evaluar la calidad de las Intervenciones farmacéuticas que motivaron un Inicio de tratamiento en un Servicio de Urgencias. Analizar el porcentaje de intervenciones sobre tratamientos agudos o crónicos, y el grupo ATC de los fármacos impl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::e187f6317086e301d7a592ebb21b05bc
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-63432014000200008&lng=en&tlng=en
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-63432014000200008&lng=en&tlng=en
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 38(2)
To assess the quality of Pharmaceutical Interventions of starting a drug treatment based on the available scientific evidence, in an Emergency Department with a Clinical Pharmacist working full-time. To analyze the rate of Pharmaceutical Intervention
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c3362a386b86e55aed7b3fcaf3e0e61c
https://pubmed.ncbi.nlm.nih.gov/24669897
https://pubmed.ncbi.nlm.nih.gov/24669897
Autor:
RM Damas Fuentes, L Laguna Marmol, MA Padrón Garcia, M Molina Fernandez-Posse, S González-Munguía, MM Díaz Pestano, M Piñero González, L Majuelos Aicart, R Molero Gómez
Publikováno v:
European Journal of Hospital Pharmacy. 22:A142.1-A142
Background Medication systems related to clinical decision support, when implemented in an electronic prescribing program, have the potential to reduce adverse drug reactions. Purpose To increase safety in the prescription and administration of drugs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87d6f2b8a1d7a1f3da24dd98f68e984d
https://doi.org/10.1136/ejhpharm-2015-000639.342
https://doi.org/10.1136/ejhpharm-2015-000639.342
Autor:
R Molero Gómez, H Alonso Ramos, L Oliva Hernandez, RM Damas Fuentes, MA Padrón Garcia, M Pérez León
Publikováno v:
European Journal of Hospital Pharmacy. 22:A10.1-A10
Background The administration of an intensive dose of statins after acute myocardial infarction (AMI) has proved to be superior to conventional doses in reducing morbidity and mortality (IA evidence) but application in clinical practice is variable.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d1f3598611dca3d6474f4d056a7407d
https://doi.org/10.1136/ejhpharm-2015-000639.23
https://doi.org/10.1136/ejhpharm-2015-000639.23
Autor:
M Pérez León, JJ Ramos Báez, M Amat López, SM Marrero Penichet, R Molero Gómez, S González Munguía, G Herrera Ortega, N Sangil Monroy, V Morales León
Publikováno v:
European Journal of Hospital Pharmacy. 22:A64.2-A64
Background Inappropriate use of antibiotics has become a serious problem in the hospital setting. We implemented a stewardship programme in order to optimise antimicrobial treatment at our hospital. Purpose To analyse the contribution of an antibioti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65673ef5412d2914d1bb35e778bc5138
https://doi.org/10.1136/ejhpharm-2015-000639.153
https://doi.org/10.1136/ejhpharm-2015-000639.153
Autor:
M Pérez León, H Luzardo-Henríquez, R Molero Gómez, M Díaz-Pestano, M Piñero González, S González-Munguía
Publikováno v:
European Journal of Hospital Pharmacy. 22:A6.1-A6
Background Allogeneic hematopoietic stem cell transplantation (HSCT) is the first-line treatment for many haematological diseases. Graft-versus-host disease (GVHD) is the major complication of HSCT. Steroids are the mainstay treatment of GVHD for red
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::351d3f362cbdab3a8a7fab930b07fe22
https://doi.org/10.1136/ejhpharm-2015-000639.13
https://doi.org/10.1136/ejhpharm-2015-000639.13
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 28(1)
Primary pulmonary hypertension (PPH) is a disease of un-known etiology that is characterized by an increase in pulmonary arterial pressure. Traditionally its treatment has been based on the administration of the vasodilator therapy with calcium chann
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7fba5f32a5da1c2361de9f291436c1a7
https://pubmed.ncbi.nlm.nih.gov/15369441
https://pubmed.ncbi.nlm.nih.gov/15369441
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 27(1)
Plasmatic coagulation has like purpose the formation of a stable clot of fibrina, this process is possible thanks to the intervention of the factors of the coagulation that are plasmatic proteins. Some of these factors are vitamin K dependent (factor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::adfa36cc4928540abb2db7343a180cf6
https://pubmed.ncbi.nlm.nih.gov/12607015
https://pubmed.ncbi.nlm.nih.gov/12607015
Autor:
M Molina Fernandez-Posse, R Molero Gómez, N Sangil Monroy, RM Damas Fuentes, MM Varela Gonzalez, L Oliva Hernandez
Publikováno v:
European Journal of Hospital Pharmacy. 21:A169.3-A170
Background Bosentan is indicated in the treatment of pulmonary hypertension. Commonly reported adverse reactions are abnormal liver function (10.9%). Purpose To evaluate the risk of hepatotoxicity associated with bosentan, comparing incidence rates w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::758c956b7fe10dcde43954f044dfdb7d
https://doi.org/10.1136/ejhpharm-2013-000436.415
https://doi.org/10.1136/ejhpharm-2013-000436.415
Autor:
G Herrera Ortega, MM Díaz Pestano, H Alonso Ramos, SM Marrero Penichet, M Amat López, ML Oliva Hernández, R Molero Gómez, M Pérez León, N Sangil Monroy, JJ Ramos Báez, S González Munguía
Publikováno v:
European Journal of Hospital Pharmacy. 21:A166.1-A166
Background Medicines reconciliation studies have produced estimates about rates of patients and drugs involved in unintended discrepancies along the reconciliation process, but to our knowledge no-one has worked out the reasons for these discrepancie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f697f1c125a64b1a18cbb417959c148
https://doi.org/10.1136/ejhpharm-2013-000436.406
https://doi.org/10.1136/ejhpharm-2013-000436.406